Concepedia

Nicole Nasholm

NN

Statistics

Publications

19

Citations

1.1K

H-Index

15

Active since

2011

Affiliations

University of California, San Francisco(Current)

National Institutes of Health

Dana-Farber Cancer Institute

Harvard University

Revolution Medicines (United States)

Nicole Nasholm is an author at University of California, San Francisco specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2024

19

Publications

19

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 268 citations · Full text

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Johanna Theruvath, Marie Ménard, Benjamin Smith et al. · Nature Medicine · 2022 · 239 citations · Full text

, , +3

CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2

Liying Chen, Gabriela Alexe, Neekesh V. Dharia et al. · Journal of Clinical Investigation · 2017 · 156 citations · Full text

, , +14

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Erin F. Simonds, Edbert D Lu, O. Badillo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 102 citations · Full text

Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling

Amanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang et al. · Cancer Cell · 2018 · 91 citations · Full text

, , +7

1–5 of 19